CLINICAL_TRIALS
trial_result
· 2023-04-07
Clinical Trial Update: A Study of Olanzapine in Patients With Acute Agitation [Phase 3]
Summary
A Phase 3 clinical trial evaluating olanzapine for acute agitation is in progress with status not specified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Acute Agitation | Phase 3 | Status: UNKNOWN